RecruitingNot ApplicableNCT06349915

A Pilot Evaluation of a Digital Peer Support Intervention for Suicidal Adolescents


Sponsor

Albert Einstein College of Medicine

Enrollment

46 participants

Start Date

Apr 1, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

Suicide risk has increased among youth in underserved communities, where access to mental healthcare is limited. To address this need, the investigator team plans to evaluate the preliminary efficacy of a brief, low-cost, culturally responsive digital intervention for ethnically diverse youth at risk for suicide in The Bronx, New York. In collaboration with community stakeholders, suicide recovery narratives, featuring adolescents' experiences related to recovery from suicidal thoughts will be developed. A smartphone ecological momentary assessment (EMA) app will be used to evaluate whether a curriculum of these narratives provides anti-suicidal benefits to at-risk adolescents.


Eligibility

Min Age: 14 YearsMax Age: 18 Years

Inclusion Criteria3

  • past-month history of suicidal thoughts
  • past-month history of Major depressive disorder
  • possession of apple or android smartphone with data plan

Exclusion Criteria4

  • inability to read/write in English
  • Active mania
  • Active psychosis
  • Autism spectrum disorder

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALSupporting Wellbeing with Everyday Experiences of Peers (SWEEP)

Each day during a 14-day trial period, participants will receive one narrative featuring lived experience with and recovery from suicidal thoughts and behaviors. These narratives will be presented in audio and text format via a smartphone app. Participants will also complete self-report surveys assessing study outcomes using the same smartphone app five times per day.


Locations(1)

Montefiore Health System

The Bronx, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06349915


Related Trials